Tower Research Capital (TRC)’s Alimera Sciences ALIM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-694
| Closed | -$3.86K | – | 6074 |
|
|
2024
Q2 | $3.86K | Sell |
694
-250
| -26% | -$888 | ﹤0.01% | 4849 |
|
|
2024
Q1 | $3.68K | Buy |
944
+644
| +215% | +$2.45K | ﹤0.01% | 4817 |
|
|
2023
Q4 | $1.3K | Sell |
300
-11,700
| -98% | -$39.5K | ﹤0.01% | 5402 |
|
|
2023
Q3 | $37.2K | Buy |
12,000
+8,937
| +292% | +$29.5K | ﹤0.01% | 2829 |
|
|
2023
Q2 | $8.94K | Sell |
3,063
-524
| -15% | -$1.2K | ﹤0.01% | 4356 |
|
|
2023
Q1 | $7K | Sell |
3,587
-382
| -10% | -$888 | ﹤0.01% | 4790 |
|
|
2022
Q4 | $11K | Buy |
3,969
+1,987
| +100% | +$8.46K | ﹤0.01% | 3903 |
|
|
2022
Q3 | $10K | Buy |
1,982
+826
| +71% | +$5.03K | ﹤0.01% | 4592 |
|
|
2022
Q2 | $6K | Buy |
+1,156
| New | +$6.36K | ﹤0.01% | 4981 |
|
|
2022
Q1 | – | Sell |
-200
| Closed | -$1K | – | 6687 |
|
|
2021
Q4 | $1K | Sell |
200
-1,291
| -87% | -$6.32K | ﹤0.01% | 5919 |
|
|
2021
Q3 | $7K | Buy |
1,491
+542
| +57% | +$3.78K | ﹤0.01% | 4691 |
|
|
2021
Q2 | $8K | Buy |
949
+852
| +878% | +$8.37K | ﹤0.01% | 4517 |
|
|
2021
Q1 | $1K | Sell |
97
-3,492
| -97% | -$28.6K | ﹤0.01% | 5232 |
|
|
2020
Q4 | $15K | Buy |
+3,589
| New | +$16.1K | ﹤0.01% | 4070 |
|
|
2020
Q3 | – | Sell |
-1,467
| Closed | -$10K | – | 5169 |
|
|
2020
Q2 | $10K | Buy |
1,467
+936
| +176% | +$4.89K | ﹤0.01% | 4026 |
|
|
2020
Q1 | $2K | Sell |
531
-2,216
| -81% | -$13.5K | ﹤0.01% | 2659 |
|
|
2019
Q4 | $21K | Buy |
+2,747
| New | +$16.4K | ﹤0.01% | 1902 |
|
|
2019
Q3 | – | Sell |
-3,657
| Closed | -$49K | – | 4609 |
|
|
2019
Q2 | $49K | Buy |
3,657
+3,646
| +33,145% | +$51.3K | ﹤0.01% | 1586 |
|
|
2019
Q1 | $0 | Sell |
11
-1,634
| -99% | -$24.9K | ﹤0.01% | 4392 |
|
|
2018
Q4 | $18K | Buy |
1,645
+1,128
| +218% | +$16.4K | ﹤0.01% | 2035 |
|
|
2018
Q3 | $8K | Buy |
517
+421
| +439% | +$6.41K | ﹤0.01% | 2914 |
|
|
2018
Q2 | $1K | Buy |
+96
| New | +$1.35K | ﹤0.01% | 3533 |
|
|
2017
Q4 | – | Sell |
-1,636
| Closed | -$33K | – | 4131 |
|
|
2017
Q3 | $33K | Buy |
+1,636
| New | +$35K | ﹤0.01% | 2367 |
|
|
2017
Q2 | – | Sell |
-229
| Closed | -$5K | – | 3593 |
|
|
2017
Q1 | $5K | Sell |
229
-202
| -47% | -$3.89K | ﹤0.01% | 2240 |
|
|
2016
Q4 | $7K | Buy |
431
+275
| +176% | +$5.03K | ﹤0.01% | 2882 |
|
|
2016
Q3 | $3K | Sell |
156
-960
| -86% | -$22.1K | ﹤0.01% | 2921 |
|
|
2016
Q2 | $21K | Buy |
+1,116
| New | +$29.7K | ﹤0.01% | 2201 |
|
|
2016
Q1 | – | Sell |
-486
| Closed | -$18K | – | 5099 |
|
|
2015
Q4 | $18K | Buy |
+486
| New | +$21.1K | ﹤0.01% | 1427 |
|
|
2015
Q3 | – | Sell |
-6
| Closed | – | – | 4930 |
|
|
2015
Q2 | $0 | Sell |
6
-187
| -97% | -$12.9K | ﹤0.01% | 5154 |
|
|
2015
Q1 | $14K | Buy |
193
+13
| +7% | +$1.02K | ﹤0.01% | 2542 |
|
|
2014
Q4 | $15K | Buy |
180
+86
| +91% | +$6.98K | ﹤0.01% | 1812 |
|
|
2014
Q3 | $8K | Sell |
94
-316
| -77% | -$27K | ﹤0.01% | 3015 |
|
|
2014
Q2 | $37K | Buy |
410
+338
| +469% | +$30K | ﹤0.01% | 1456 |
|
|
2014
Q1 | $9K | Sell |
72
-27
| -27% | -$2.62K | ﹤0.01% | 2737 |
|
|
2013
Q4 | $7K | Buy |
+99
| New | +$4.04K | ﹤0.01% | 3322 |
|
|
2013
Q3 | – | Sell |
-202
| Closed | -$15K | – | 4908 |
|
|
2013
Q2 | $15K | Buy |
+202
| New | +$11.7K | ﹤0.01% | 1992 |
|
Tower Research Capital (TRC)'s ALIM Position: Q3 2024 in Review
Tower Research Capital (TRC) sold out of Alimera Sciences (ALIM) in Q3 2024, closing a stake of 694 shares — an estimated $3.86K sold.
Tower Research Capital (TRC) first reported a position in ALIM in Q2 2013 and held it in 36 quarters. The position peaked at $49K in Q2 2019. 0 funds tracked by Wall St. Rank hold ALIM as of Q3 2024.
- Tower Research Capital (TRC) reported no remaining Alimera Sciences position as of Q3 2024 after selling out during the quarter.
- Tower Research Capital (TRC) sold 694 Alimera Sciences shares in Q3 2024, an estimated $3.86K.
- Tower Research Capital (TRC) first reported a position in Alimera Sciences in Q2 2013 and held it in 36 quarters.
- Tower Research Capital (TRC)'s Alimera Sciences position peaked at $49K in Q2 2019.
- 0 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2024.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2024, filed 14 Nov 2024.